| Phase 16 trials |
|
Phase 1
|
NCT06680531 |
Aug → Sep 2024 |
insomnia |
Shanghai Haiyan Pharmaceutical Technology Co., Ltd. |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT06671470 |
Aug → Sep 2024 |
insomnia |
Shanghai Haiyan Pharmaceutical Technology Co., Ltd. |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT06671444 |
Jun → Oct 2024 |
impaired renal function disease, insomnia |
Shanghai Haiyan Pharmaceutical Technology Co., Ltd. |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT06671509 |
Mar → Apr 2024 |
insomnia |
Shanghai Haiyan Pharmaceutical Technology Co., Ltd. |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT06685341 |
Mar → Apr 2019 |
insomnia |
Shanghai Haiyan Pharmaceutical Technology Co., Ltd. |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT06673927 |
Dec 2017 → Nov 2018 |
insomnia |
Shanghai Haiyan Pharmaceutical Technology Co., Ltd. |
Completed
|
No outcome recorded
|
| Phase 21 trial |
|
Phase 2
|
NCT06680505 |
Aug 2019 → Sep 2020 |
insomnia |
Shanghai Haiyan Pharmaceutical Technology Co., Ltd. |
Completed
|
No outcome recorded
|
| Phase 32 trials |
|
Phase 3
|
NCT06975514 |
Mar → Jul 2025 |
insomnia |
Shanghai Haiyan Pharmaceutical Technology Co., Ltd. |
Completed
|
No outcome recorded
|
|
Phase 3
|
NCT05525637 |
Dec 2021 → Jul 2023 |
insomnia |
Shanghai Haiyan Pharmaceutical Technology Co., Ltd. |
Completed
|
No outcome recorded
|